glp-1 and gip receptor agonist Dual GIP/GLP-1 agonists: New advances for treating type-2 diabetes LY3437943, a novel triple glucagon,
Description
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: past, present, and future
GLP-1 medications offer notable sleep improvements for individuals struggling with this condition
These effects could be at least partially attributed to the slowing of gastric emptying
Nat Rev Dis Primers (2016) 2:16057
